NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $43,544,000 | +33.2% | 1,217,320 | -3.2% | 0.22% | +43.0% |
Q3 2014 | $32,690,000 | -43.0% | 1,257,320 | -27.6% | 0.15% | -34.3% |
Q2 2014 | $57,399,000 | -30.8% | 1,736,720 | -37.3% | 0.23% | -29.4% |
Q1 2014 | $82,936,000 | -24.9% | 2,771,000 | -23.8% | 0.33% | -22.7% |
Q4 2013 | $110,368,000 | -21.9% | 3,635,300 | -18.2% | 0.42% | -26.0% |
Q3 2013 | $141,395,000 | +79.8% | 4,445,000 | -14.6% | 0.57% | +65.7% |
Q2 2013 | $78,626,000 | – | 5,207,000 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 424,175 | $12,695,000 | 5.06% |
Opaleye Management Inc. | 150,000 | $4,490,000 | 3.32% |
OAK RIDGE INVESTMENTS LLC | 2,795,331 | $83,664,000 | 2.10% |
SCHOLTZ & COMPANY, LLC | 60,350 | $1,806,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 1,408,729 | $42,163,000 | 1.73% |
First Light Asset Management, LLC | 79,099 | $2,367,000 | 1.68% |
FCG ADVISORS, LLC | 71,146 | $2,129,000 | 1.51% |
Rhenman & Partners Asset Management AB | 166,970 | $4,997,000 | 1.50% |
BENDER ROBERT & ASSOCIATES | 73,611 | $2,203,000 | 1.48% |
Eventide Asset Management | 283,900 | $8,497,000 | 1.32% |